Steven S. Williamson - Mar 3, 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: PRESIDENT AND CEO, Director
Signature: /s/ David Aaron Lehman, Attorney-in-Fact
Stock symbol: LUNG
Transactions as of: Mar 3, 2025
Transactions value $: -$197,699
Form type: 4
Date filed: 3/5/2025, 06:09 PM
Previous filing: Aug 22, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Sale	-$198K	-27.7K	-12.47%	$7.14	194K	Mar 3, 2025	Direct	F1, F2
transaction	LUNG	Common Stock	Award	$0	+182K	+93.49%	$0.00	376K	Mar 3, 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Award	$0	+128K		$0.00	128K	Mar 3, 2025	Common Stock	128K	$8.29	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 15, 2024.
F2	Includes 2,500 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2025.
F3	Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.
F4	The shares subject to the option vest in 48 equal monthly installments from the grant date on March 3, 2025.